Skip to main content
. 2019 Aug 1;24(11):1479–1487. doi: 10.1634/theoncologist.2018-0724

Table 2. Baseline treatment characteristics among patients with relapsed/refractory multiple myeloma.

image

Abbreviations: d, dexamethasone; IMID, immunomodulatory drug; IQR, interquartile range; mAb, monoclonal antibody; PI, proteasome inhibitor.